Co-Authors
This is a "connection" page, showing publications co-authored by Binita Shah and Michael Pillinger.
Connection Strength
1.330
-
Response to: 'Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'' by Perricone et al. Ann Rheum Dis. 2021 Jan 28.
Score: 0.926
-
Anti-inflammatory therapy for COVID-19 infection: the case for colchicine. Ann Rheum Dis. 2021 05; 80(5):550-557.
Score: 0.229
-
C-reactive protein and clinical outcomes in patients with COVID-19. Eur Heart J. 2021 06 14; 42(23):2270-2279.
Score: 0.059
-
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial. Lancet Respir Med. 2021 08; 9(8):924-932.
Score: 0.059
-
COVID-19 and the Heart and Vasculature: Novel Approaches to Reduce Virus-Induced Inflammation in Patients With Cardiovascular Disease. Arterioscler Thromb Vasc Biol. 2020 09; 40(9):2045-2053.
Score: 0.056